Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$16.00 USD
+0.14 (0.88%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $16.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Korro Bio, Inc. has a market cap of $148.93M, which represents its share price of $15.86 multiplied by its outstanding shares number of 9.39M. As a small-cap company, KRRO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
KRRO 16.00 +0.14(0.88%)
Will KRRO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KRRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KRRO
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data
Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet
KRRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for KRRO
Korro Bio (KRRO) Buy Rating Reiterated by HC Wainwright & Co. | KRRO Stock News
Korro Bio (KRRO) Secures EMA Orphan Drug Designation for KRRO-110 | KRRO Stock News
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 | KRRO Stock News
Korro Bio receives European Medicines Agency granted ODD for KRRO-110
Korro Bio management to meet with Piper Sandler